Doyugan, Katherine D.

HRN: 19-29-29  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
12/23/2025
12/25/2025
SLOW IVTT
325mg (5mkd)
Q24h
Elective D&c
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines